Nitroglycerin attenuates vasoconstriction of HBOC-201 during hemorrhagic shock resuscitation.

[1]  M. Weyand,et al.  Inhibition of aldehyde dehydrogenase type 2 attenuates vasodilatory action of nitroglycerin in human veins , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[2]  M. Gladwin,et al.  Nitrite reductase activity of hemoglobin as a systemic nitric oxide generator mechanism to detoxify plasma hemoglobin produced during hemolysis. , 2008, American journal of physiology. Heart and circulatory physiology.

[3]  C. Natanson,et al.  Cell-free hemoglobin-based blood substitutes and risk of myocardial infarction and death: a meta-analysis. , 2008, JAMA.

[4]  W. Zapol,et al.  Inhaled Nitric Oxide Enables Artificial Blood Transfusion Without Hypertension , 2008, Circulation.

[5]  J. Takala,et al.  The Immediate and Sustained Effects of Volume Challenge on Regional Blood Flows in Pigs , 2008, Anesthesia and analgesia.

[6]  Ernest E Moore,et al.  The next generation in shock resuscitation , 2004, The Lancet.

[7]  K. Proctor.  Blood substitutes and experimental models of trauma. , 2003, The Journal of trauma.

[8]  G. Manley,et al.  Tissue oxygen monitoring during hemorrhagic shock and resuscitation: a comparison of lactated Ringer's solution, hypertonic saline dextran, and HBOC-201. , 2003, The Journal of trauma.

[9]  L. Pearce,et al.  HBOC-201 improves survival in a swine model of hemorrhagic shock and liver injury. , 2002, Resuscitation.

[10]  A. Popel,et al.  Model of nitric oxide diffusion in an arteriole: impact of hemoglobin-based blood substitutes. , 2002, American journal of physiology. Heart and circulatory physiology.

[11]  V. Brower.  Fast tracking drugs to patients , 2002 .

[12]  T. Standl.  Haemoglobin-based erythrocyte transfusion substitutes , 2001, Expert opinion on biological therapy.

[13]  R. Patel,et al.  Biochemical aspects of the reaction of hemoglobin and NO: implications for Hb-based blood substitutes. , 2000, Free radical biology & medicine.

[14]  N. Marsh,et al.  A Short History Of Nitroglycerine And Nitric Oxide In Pharmacology And Physiology , 2000, Clinical and experimental pharmacology & physiology.

[15]  L. Pearce,et al.  Bovine hemoglobin-based oxygen carrier (HBOC-201) for resuscitation of uncontrolled, exsanguinating liver injury in swine. Carolina Resuscitation Research Group. , 2000, Shock.

[16]  K. Burhop,et al.  Effect of α-α Diaspirin Crosslinked Hemoglobin (DCLHbTM) on the Potency of Sodium Nitroprusside and Nitroglycerine to Decrease Blood Pressure in Rats: A Dose-Response Study , 2000, Artificial cells, blood substitutes, and immobilization biotechnology.

[17]  J. Olson,et al.  Rate of reaction with nitric oxide determines the hypertensive effect of cell-free hemoglobin , 1998, Nature Biotechnology.

[18]  R. Shorr,et al.  Hemoglobin based oxygen carriers: how much methemoglobin is too much? , 1998, Artificial cells, blood substitutes, and immobilization biotechnology.

[19]  E. Troncy,et al.  Extra-pulmonary effects of inhaled nitric oxide in swine with and without phenylephrine. , 1997, British journal of anaesthesia.

[20]  F. Marceau,et al.  Recombinant Human Hemoglobin (rHb1.1) Selectively Inhibits Vasorelaxation Elicited by Nitric Oxide Donors in Rabbit Isolated Aortic Rings , 1995, Journal of cardiovascular pharmacology.

[21]  C. Valeri,et al.  Stroma-free hemoglobin increases blood pressure and GFR in the hypotensive rat: role of nitric oxide. , 1994, Journal of applied physiology.

[22]  Z. Ba,et al.  Endothelial cell dysfunction occurs very early following trauma-hemorrhage and persists despite fluid resuscitation. , 1993, The American journal of physiology.

[23]  M. Mythen,et al.  Pharmacology and physiology of colloids. , 1993, Blood reviews.

[24]  F. Cobb,et al.  Heterogeneous effects of nitroglycerin on the conductance and resistance coronary arterial vasculature. , 1993, The American journal of physiology.

[25]  M. Lewis,et al.  SIN‐1 Reduces Platelet Adhesion and Platelet Thrombus Formation in a Porcine Model of Balloon Angioplast , 1993, Circulation.

[26]  J. Schrader,et al.  Release of endothelium derived nitric oxide in relation to pressure and flow. , 1991, Cardiovascular research.

[27]  S. Moncada,et al.  Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.

[28]  M. Feelisch,et al.  Nitric oxide (NO) formation from nitrovasodilators occurs independently of hemoglobin or non-heme iron. , 1987, European journal of pharmacology.

[29]  L. Benet,et al.  Dose dependent pharmacokinetics of nitroglycerin after multiple intravenous infusions in healthy volunteers , 1985, Journal of Pharmacokinetics and Biopharmaceutics.

[30]  E. Braunwald,et al.  Efforts to limit the size of myocardial infarcts. , 1981, Annals of internal medicine.

[31]  A. Yacobi,et al.  Nitroglycerin pharmacokinetics after intravenous infusion in normal subjects. , 1981, Journal of pharmaceutical sciences.

[32]  W. Drucker,et al.  Hemodynamic and metabolic alterations in peripheral tissue during hemorrhagic shock. , 1975, The American surgeon.

[33]  L. Pearce,et al.  The pharmacology of tissue oxygenation by biopure's hemoglobin-based oxygen carrier, Hemopure (HBOC-201). , 2003, Advances in experimental medicine and biology.

[34]  V. Brower.  Fast tracking drugs to patients. Drug approval agencies are frequently criticised for either being too slow or too fast. , 2002, EMBO reports.

[35]  C. Natanson,et al.  Cardiopulmonary effects of inhaled nitric oxide in normal dogs and during E. coli pneumonia and sepsis. , 1998, Journal of applied physiology.

[36]  K. Bilello,et al.  Diaspirin crosslinked hemoglobin (DCLHb): control of pressor effect with anti-hypertensive agents. , 1994, Artificial cells, blood substitutes, and immobilization biotechnology.

[37]  A. Auricchio,et al.  Coronary vasodilation with nitrocompounds--is there a maximum? , 1989, Zeitschrift fur Kardiologie.

[38]  K. Tremper,et al.  Blood and plasma substitutes--plasma expansion and oxygen transport properties. , 1985, The Western journal of medicine.

[39]  M. Doyle,et al.  Oxidation of nitrogen oxides by bound dioxygen in hemoproteins. , 1981, Journal of inorganic biochemistry.